Search

Search bills, members, committees and pages...

Sign In

H.R. 88

U.S. House•In House Committee

Summary

H.R. 88, the Medical Innovation Acceleration Act of 2025, was introduced in the House on Jan 3, 2025 by Rep. Andy Biggs (R). It was referred to Energy And Commerce, and last saw action on Jan 3, 2025: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 88 has no co-sponsors and has not gone to a roll call.

hb88/introduced-in-house.txt
119 HR 88 IH: Medical Innovation Acceleration Act of 2025
 U.S. House of Representatives
 2025-01-03
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 88  IN THE HOUSE OF REPRESENTATIVES   January 3, 2025   Mr. Biggs of Arizona  introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.
1.
Short title
This Act may be cited as the   Medical Innovation Acceleration Act of 2025  .
2.
Exempting non-invasive diagnostic devices from regulation as devices
Section 201(h) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(h) ) is amended—
(1)
by striking  section 520(o)  and inserting the following:  section 520(o) or any non-invasive diagnostic device ; and
(2)
by adding at the end the following:  For purposes of the preceding sentence, the term  non-invasive  means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation. .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-01-03
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Jan 3, 2025

hb88/introduced-in-house.md

Shown Here:
Introduced in House (01/03/2025)

Sponsors

Rep. Andy Biggs (R) sponsors H.R. 88 alone.

Andy Biggs

Rep. · R–AZ-5 · Sponsor

Committees

H.R. 88 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Jan 3, 2025 · 1,636 Bills

Actions

H.R. 88 has taken 2 actions since Jan 3, 2025.

ChamberAction
Jan 3, 2025
House
Introduced in House
Jan 3, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 88 has not gone to a roll call.

Titles

H.R. 88 goes by 3 titles, 1 of them short titles.

  • Medical Innovation Acceleration Act of 2025 — Display Title
  • Medical Innovation Acceleration Act of 2025 — Short Title(s) as Introduced
  • To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes. — Official Title as Introduced

Classification

The Congressional Research Service files H.R. 88 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 88’s is Health.

hr88/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Source: congress.gov · legiscan.com